Cell Point (India) (NSE:CELLPOINT) ROCE %: 8.79% (As of Mar. 2026)


NSE:CELLPOINT Cell Point (India) Ltd NSE:CELLPOINT
73 GF Score
Price ₹15.00
GF Value ₹34.72
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Cell Point (India) ROCE %?

Cell Point (India) NSE:CELLPOINT -5.36% 73 ROCE % is 8.79% as of Mar. 2026. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 73/100 and a GF Value™ of ₹34.72 (Significantly Undervalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cell Point (India)'s annualized ROCE % for the quarter that ended in Mar. 2026 was 8.79%.

Cell Point (India)  (NSE:CELLPOINT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Cell Point (India) ROCE % Related Terms

Cell Point (India) ROCE % Historical Data

* Premium members only.

The historical data trend for Cell Point (India)'s ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Point (India) ROCE % Chart

Cell Point (India) Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 24.65 45.10 14.11 10.69 8.15

Cell Point (India) Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.63 7.63 13.67 8.05 8.79
NSE:CELLPOINT
73GF Score
Cell Point (India) Ltd NSE:CELLPOINT
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cell Point (India) ROCE % Calculation

Cell Point (India)'s annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=74.128/( ( (1381.582 - 624.018) + (1691.05 - 629.831) )/ 2 )
=74.128/( (757.564+1061.219)/ 2 )
=74.128/909.3915
=8.15 %

Cell Point (India)'s ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=83.758/( ( (1626.091 - 780.617) + (1691.05 - 629.831) )/ 2 )
=83.758/( ( 845.474 + 1061.219 )/ 2 )
=83.758/953.3465
=8.79 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 8.79% mean?
Cell Point (India) (NSE:CELLPOINT) has a ROCE % of 8.79% as of Mar. 2026.
Is Cell Point (India)'s ROCE % too high?
Cell Point (India)'s current ROCE % is 8.79%. The Retail - Cyclical industry median ROCE % is 7.58. Cell Point (India)'s value of 8.79% is 16% above this industry median. Overall, Cell Point (India) has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s ROCE % compare to CASY and WSM?
Cell Point (India)'s ROCE % of 8.79% can be compared against companies in the Retail - Cyclical industry. The industry median ROCE % is 7.58. Cell Point (India)'s value of 8.79% is 16% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Retail - Cyclical company?
The median ROCE % among Retail - Cyclical companies is 7.58, based on 1,117 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cell Point (India)'s current ROCE % of 8.79% is 16% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Retail - Cyclical industry, the median ROCE % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Point (India)'s current ROCE % is 8.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹34.72, compared to a current price of ₹15.00 — trading 56.8% below its estimated fair value. The current ROCE % is 8.79% and 16% above the Retail - Cyclical industry median of 7.58. Cell Point (India)'s overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current ROCE % is 8.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued. The current stock price of ₹15.00 is trading 56.8% below its estimated GF Value™ of ₹34.72. GuruFocus considers Cell Point (India) to be Significantly Undervalued.

Key valuation signals for NSE:CELLPOINT:

  • ROCE %: 8.79%
  • GF Value™: ₹34.72 vs. price of ₹15.00 (56.8% below fair value)
  • GF Score™: 73/100 with 7 warning signs
  • Industry Position: 16% above the Retail - Cyclical median

No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cell Point (India) Business Description

Address Lalitha Colony, Door No. 30-15-134, Dabagardens, Visakhapatnam, AP, IND, 530020
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
73GF Score

Get the complete analysis for NSE:CELLPOINT

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.00
Price
₹34.72
GF Value